ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TEVA Teva Pharmaceutical Industries Ltd

13.37
0.05 (0.38%)
Pre Market
Last Updated: 20:14:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Teva Pharmaceutical Industries Ltd TEVA NYSE Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.05 0.38% 13.37 20:14:01
Open Price Low Price High Price Close Price Previous Close
13.32
more quote information »

Recent News

Date Time Source Heading
08/3/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202408:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
24/2/202412:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202412:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
21/2/202400:30BWTeva Presents New Data Supporting Safety, Tolerability and..
14/2/202401:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
13/2/202409:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
13/2/202401:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
01/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:00EDGAR2Form 8-K - Current report
31/1/202423:00BWTeva Reports Growth in Fourth Quarter and Full Year 2023
31/1/202422:00BWTeva Announces Intention to Divest API Business as Part of..
03/1/202408:30BWTeva to Host Conference Call to Discuss Fourth Quarter and..
03/1/202400:50DJNCorcept Therapeutics Shares Slide Premarket on Loss in Teva..
29/12/202308:30BWTeva to Present at the 42nd Annual J.P. Morgan Healthcare..
15/12/202300:30BWTeva and Biolojic Design Announce Exclusive License..
07/12/202303:19BWNeue Post-Hoc-Analyse von Phase-3-Daten zeigt, dass AJOVY®..
07/12/202301:24BWUne nouvelle analyse post hoc des données de phase 3 montre..
06/12/202318:00BWNew Post Hoc Phase 3 Data Analysis Shows AJOVY®..
01/12/202301:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
01/12/202300:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
22/11/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202308:30BWTeva to Present at the 6th Annual Evercore ISI HealthCONx..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com